U.S. Gene Editing Market Report 2022: Emergence of Novel Gene Editing Tools Presents Opportunities

News provided by

Nov 25, 2022, 11:15 ET

DUBLIN, Nov. 25, 2022 /PRNewswire/ -- The "U.S. Gene Editing Market - Industry Outlook & Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The U.S. gene editing market is expected to grow at a CAGR of 21.13% during 2022-2027.

MARKET INSIGHTS

Growth in the gene editing market is fueled by increasing demand for synthetic genes in the U.S. Genomics can be used to identify genetic abnormalities in humans, drug discovery, agriculture, veterinary medicine, and forensics. Gene editing requires tools and techniques that make unique changes to the DNA sequence of an organism's genes, fundamentally altering the genetic blueprint. Unlike genetic engineering, which randomly incorporates genetic material into the host genome, gene editing aims to make changes at specific target locations.

Genome editing technology is a technique for target gene modification that allows the knockout and addition of specific fragments of DNA. This technique is widely used in biomedical research, clinics, and agriculture. A growing preference for personalized medicine, rare disease treatment research, rising R&D spending and growth in the pharmaceutical and biotech industries, rapid advances in sequencing and genome editing technologies, and increasing use of products derived from genetically modified organisms. These are some of the factors that are boosting the growth of the U.S. gene editing market.

Market Dynamics

Market Opportunities & Trends

Emergence of Novel Gene Editing Tools
Use of Gene Editing in Personalized Medicine
Increased Pharma/Biotech, Venture Capital & Government Funding for Gene Editing Projects
High Number of Gene Editing-Based Investigational Drugs

Market Growth Enablers

Advances in Genome Editing Platforms
Large Target Population With Rare Genetic Disorders
Demand for Gene Editing in Drug Discovery & Development
Diverse Applications of Gene Editing

Market Restraints

High Cost & Time Involved in Gene Editing
Technical Challenges Related to Gene Editing
Ethical & Safety Concerns Associated With Gene Editing

SEGMENTATIONS

Segmentation by Products

Reagents & Consumables
Equipment & Software
Services

Segmentation by Technology

CRISPER
TALEN
ZFN
Others

Segmentation by Application

Drug Discovery & Development (DDD)
Animal Gene Editing
Plant Gene Editing
Others

Segmentation by End User

Pharma & Biotech Companies (PBC)
Academic & Research Institutes (ARI)
Animal & Plant Biotech Companies (APBC)
CROs/CDMOs

Key Vendors

Agilent Technologies
Creative Biogene
Genscript
Merck KGaA
Thermo Fisher Scientific
Takara Bio

Other Prominent Vendors

Arbor Biotechnologies
Beam Therapeutics
Bluebird Bio
Cellectis
Caribou Biosciences
Charles River Laboratories
CRISPR Therapeutics
HERA Biolabs
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Synthego
Tecan
PerkinElmer
Precision BioSciences
Intellia Therapeutics
Pairwise
Sangamo Therapeutics
Recombinetics
Synbio Technologies

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

5 Report Assumptions & Caveats

6 Market at a Glance

7 Premium Insights

8 Introduction

9 Market Opportunities & Trends

10 Market Growth Enablers

11 Market Restraints

12 Market Landscape

13 Product

14 Technology

15 Application

16 End-User

17 Competitive Landscape

18 Key Company Profiles

19 Other Prominent Vendors

20 Report Summary

21 Quantitative Summary

22 Appendix

Companies Mentioned